Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cadonilimab”

148 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 148 results

Testing effectiveness (Phase 2)Looking for participantsNCT06650332
What this trial is testing

Cadonilimab Combination Regimen as First-line Treatment for HER2-expressing GC/GEJ Patients

Who this might be right for
Metastatic HER2 Positive Gastroesophageal Junction Cancer
Zhejiang Cancer Hospital 90
Testing effectiveness (Phase 2)Looking for participantsNCT06367075
What this trial is testing

A Trial of Cadonilimab With Adriamycin in Patients With Advanced Soft Tissue Sarcoma

Who this might be right for
Advanced Soft-tissue Sarcoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 53
Testing effectiveness (Phase 2)Looking for participantsNCT06769971
What this trial is testing

Phase II Study of Ivonescimab and Cadonilimab in Combination with Chemotherapy in Patients with ES-SCLC

Who this might be right for
Small Cell Lung Cancer
Sichuan University 80
Testing effectiveness (Phase 2)UnknownNCT05839470
What this trial is testing

Cadonilimab Plus FOLFOXIRI and Bevacizumab as First Line Therapy for Metastatic MSS Colorectal Cancer

Who this might be right for
Colorectal Cancer
Fujian Cancer Hospital 20
Testing effectiveness (Phase 2)Study completedNCT06138496
What this trial is testing

Cadonilimab Combination With Lenvatinib as Neoadjuvant Therapy for ccRCC

Who this might be right for
Clear Cell Renal Cell Carcinoma
Sun Yat-sen University 39
Very early researchLooking for participantsNCT07586904
What this trial is testing

Efficacy and Safety of Neoadjuvant Cadonilimab Plus High-Dose Recombinant Human Interferon α1b in Stage III/IV Melanoma.

Who this might be right for
Melanoma (Skin Cancer)
Xijing Hospital 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06586294
What this trial is testing

Anti-PD-1 and LAG-3 Bispecific Antibody(AK129) Combined With Chemotherapy With or Without Cadonilimab in the First-line Treatment of Unresectable Locally Advanced or Metastatic G/ GEJ Adenocarcinoma

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
Akeso 294
Testing effectiveness (Phase 2)Looking for participantsNCT06654011
What this trial is testing

IN10018 With Nab-Paclitaxel and Cadonilimab for Metastatic or Recurrent Gastric-Type Cervical Adenocarcinoma: Phase 2 Trial

Who this might be right for
Cervical AdenocarcinomaGastric-type Endocervical Adenocarcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06416930
What this trial is testing

Study of Cadonilimab Combined With Chemotherapy in Recurrent / Refractory Pleural Mesothelioma

Who this might be right for
Pleural Mesothelioma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 59
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06577961
What this trial is testing

Vorolanib Combined With Cadonilimab in the Treatment of Untreated Advanced RCC Patients

Who this might be right for
Kidney CancerRCCRenal Cell Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 37
Testing effectiveness (Phase 2)UnknownNCT05821361
What this trial is testing

HAIC Combined With Cadonilimab and Bevacizumab as First-line Therapy in Unresectable Hepatocellular Carcinoma

Who this might be right for
Unrescetable Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT06532617
What this trial is testing

Cadonilimab Combined With S-1 or Capecitabine as Second-line Treatment for Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 30
Large-scale testing (Phase 3)Looking for participantsNCT07023315
What this trial is testing

A Phase III Clinical Study of Cadonilimab Plus SOX as Perioperative Treatment for Patients With Resectable G/GEJ Adenocarcinoma

Who this might be right for
Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma
Akeso 760
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06066216
What this trial is testing

Cadonilimab (AK104) Plus Chemotherapy in Patients With Recurrent or Advanced Endometrial Cancer

Who this might be right for
Endometrial CancerEndometrial Adenocarcinoma
Fujian Cancer Hospital 45
Not applicableEnrolling By InvitationNCT06714084
What this trial is testing

CNCMT：a Multi-center, Prospective, Single-arm Study

Who this might be right for
Locally Advanced Cervical CancerPD1CTLA4
Hubei Cancer Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT06406634
What this trial is testing

Cadonilimab in Combination With Lenvatinib and Hepatic Arterial Infusion Chemotherapy (HAIC) for the Treatment of Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Hunan Cancer Hospital 30
Not applicableLooking for participantsNCT06551207
What this trial is testing

Cadonilimab Combined With Fruquintinib and SBRT as Athird-line and Posterior Line Treatment in Patients With MSS CRC

Who this might be right for
Metastatic Colorectal Cancer
Liu Huang 80
Testing effectiveness (Phase 2)UnknownNCT05948449
What this trial is testing

To Evaluate the Efficacy and Safety of Cadonilimab With SOX as Neoadjuvant Therapy for Resectable Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma.

Who this might be right for
Gastric Cancer
Sichuan University 37
Testing effectiveness (Phase 2)UnknownNCT05925413
What this trial is testing

Cadonilimab Plus TACE in Patients With Intermediate-stage Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital 41
Testing effectiveness (Phase 2)Looking for participantsNCT05960955
What this trial is testing

Cadonilimab Combination With Chemotherapy With or Without AK117 in Resectable Gastric or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Resectable Gastric or Gastroesophageal Junction Adenocarcinoma
Akeso 90
Load More Results